nodes	percent_of_prediction	percent_of_DWPC	metapath
Codeine—osteoarthritis—Prednisone—systemic scleroderma	0.563	1	CpDpCtD
Codeine—UGT2B7—Mycophenolic acid—systemic scleroderma	0.173	0.52	CbGbCtD
Codeine—UGT2B7—Mycophenolate mofetil—systemic scleroderma	0.0966	0.29	CbGbCtD
Codeine—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0254	0.0765	CbGbCtD
Codeine—CYP2D6—Captopril—systemic scleroderma	0.0198	0.0596	CbGbCtD
Codeine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.00992	0.0298	CbGbCtD
Codeine—CYP3A4—Prednisone—systemic scleroderma	0.00793	0.0238	CbGbCtD
Codeine—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.000216	0.00207	CcSEcCtD
Codeine—Hypotension—Azathioprine—systemic scleroderma	0.000216	0.00207	CcSEcCtD
Codeine—Polyuria—Methotrexate—systemic scleroderma	0.000216	0.00207	CcSEcCtD
Codeine—Cardiac arrest—Prednisone—systemic scleroderma	0.000215	0.00207	CcSEcCtD
Codeine—Tremor—Lisinopril—systemic scleroderma	0.000215	0.00207	CcSEcCtD
Codeine—Mood swings—Prednisone—systemic scleroderma	0.000215	0.00206	CcSEcCtD
Codeine—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.000215	0.00206	CcSEcCtD
Codeine—Discomfort—Mycophenolic acid—systemic scleroderma	0.000215	0.00206	CcSEcCtD
Codeine—Nervous system disorder—Leflunomide—systemic scleroderma	0.000214	0.00205	CcSEcCtD
Codeine—Pruritus—Mometasone—systemic scleroderma	0.000213	0.00205	CcSEcCtD
Codeine—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000213	0.00205	CcSEcCtD
Codeine—Tachycardia—Leflunomide—systemic scleroderma	0.000213	0.00204	CcSEcCtD
Codeine—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000212	0.00204	CcSEcCtD
Codeine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000211	0.00203	CcSEcCtD
Codeine—Angioedema—Lisinopril—systemic scleroderma	0.00021	0.00202	CcSEcCtD
Codeine—Confusional state—Mycophenolic acid—systemic scleroderma	0.00021	0.00202	CcSEcCtD
Codeine—Body temperature increased—Captopril—systemic scleroderma	0.000209	0.00201	CcSEcCtD
Codeine—Abdominal pain—Captopril—systemic scleroderma	0.000209	0.00201	CcSEcCtD
Codeine—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000208	0.002	CcSEcCtD
Codeine—Anorexia—Leflunomide—systemic scleroderma	0.000208	0.002	CcSEcCtD
Codeine—Nausea—Pentoxifylline—systemic scleroderma	0.000208	0.00199	CcSEcCtD
Codeine—Malaise—Lisinopril—systemic scleroderma	0.000207	0.00199	CcSEcCtD
Codeine—Vertigo—Lisinopril—systemic scleroderma	0.000206	0.00198	CcSEcCtD
Codeine—Syncope—Lisinopril—systemic scleroderma	0.000206	0.00198	CcSEcCtD
Codeine—Shock—Mycophenolic acid—systemic scleroderma	0.000205	0.00197	CcSEcCtD
Codeine—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000204	0.00196	CcSEcCtD
Codeine—Hypotension—Leflunomide—systemic scleroderma	0.000204	0.00196	CcSEcCtD
Codeine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000203	0.00195	CcSEcCtD
Codeine—Palpitations—Lisinopril—systemic scleroderma	0.000203	0.00195	CcSEcCtD
Codeine—Loss of consciousness—Lisinopril—systemic scleroderma	0.000202	0.00194	CcSEcCtD
Codeine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000201	0.00193	CcSEcCtD
Codeine—Visual disturbance—Methotrexate—systemic scleroderma	0.0002	0.00192	CcSEcCtD
Codeine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000199	0.00192	CcSEcCtD
Codeine—Anorexia—Mycophenolic acid—systemic scleroderma	0.000198	0.00191	CcSEcCtD
Codeine—Tension—Mycophenolate mofetil—systemic scleroderma	0.000198	0.0019	CcSEcCtD
Codeine—Insomnia—Leflunomide—systemic scleroderma	0.000197	0.0019	CcSEcCtD
Codeine—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000196	0.00188	CcSEcCtD
Codeine—Anxiety—Lisinopril—systemic scleroderma	0.000195	0.00187	CcSEcCtD
Codeine—Dyspnoea—Leflunomide—systemic scleroderma	0.000195	0.00187	CcSEcCtD
Codeine—Hypotension—Mycophenolic acid—systemic scleroderma	0.000195	0.00187	CcSEcCtD
Codeine—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000194	0.00186	CcSEcCtD
Codeine—Discomfort—Lisinopril—systemic scleroderma	0.000193	0.00186	CcSEcCtD
Codeine—Pancreatitis—Prednisone—systemic scleroderma	0.000192	0.00184	CcSEcCtD
Codeine—Vomiting—Mometasone—systemic scleroderma	0.000192	0.00184	CcSEcCtD
Codeine—Dry mouth—Lisinopril—systemic scleroderma	0.000191	0.00184	CcSEcCtD
Codeine—Sweating increased—Prednisone—systemic scleroderma	0.000191	0.00183	CcSEcCtD
Codeine—Feeling abnormal—Azathioprine—systemic scleroderma	0.00019	0.00183	CcSEcCtD
Codeine—Rash—Mometasone—systemic scleroderma	0.00019	0.00182	CcSEcCtD
Codeine—Asthenia—Captopril—systemic scleroderma	0.00019	0.00182	CcSEcCtD
Codeine—Dermatitis—Mometasone—systemic scleroderma	0.00019	0.00182	CcSEcCtD
Codeine—Decreased appetite—Leflunomide—systemic scleroderma	0.00019	0.00182	CcSEcCtD
Codeine—Confusional state—Lisinopril—systemic scleroderma	0.000189	0.00182	CcSEcCtD
Codeine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000189	0.00181	CcSEcCtD
Codeine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000189	0.00181	CcSEcCtD
Codeine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000188	0.00181	CcSEcCtD
Codeine—Insomnia—Mycophenolic acid—systemic scleroderma	0.000188	0.00181	CcSEcCtD
Codeine—Fatigue—Leflunomide—systemic scleroderma	0.000188	0.00181	CcSEcCtD
Codeine—Pruritus—Captopril—systemic scleroderma	0.000187	0.0018	CcSEcCtD
Codeine—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000187	0.00179	CcSEcCtD
Codeine—Constipation—Leflunomide—systemic scleroderma	0.000187	0.00179	CcSEcCtD
Codeine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000186	0.00178	CcSEcCtD
Codeine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000185	0.00178	CcSEcCtD
Codeine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000185	0.00178	CcSEcCtD
Codeine—Shock—Lisinopril—systemic scleroderma	0.000184	0.00177	CcSEcCtD
Codeine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000184	0.00177	CcSEcCtD
Codeine—Tachycardia—Lisinopril—systemic scleroderma	0.000183	0.00176	CcSEcCtD
Codeine—Body temperature increased—Azathioprine—systemic scleroderma	0.000183	0.00175	CcSEcCtD
Codeine—Abdominal pain—Azathioprine—systemic scleroderma	0.000183	0.00175	CcSEcCtD
Codeine—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000182	0.00174	CcSEcCtD
Codeine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000181	0.00174	CcSEcCtD
Codeine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000181	0.00174	CcSEcCtD
Codeine—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000181	0.00174	CcSEcCtD
Codeine—Irritability—Methotrexate—systemic scleroderma	0.000181	0.00174	CcSEcCtD
Codeine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000181	0.00173	CcSEcCtD
Codeine—Feeling abnormal—Leflunomide—systemic scleroderma	0.00018	0.00173	CcSEcCtD
Codeine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00018	0.00173	CcSEcCtD
Codeine—Fatigue—Mycophenolic acid—systemic scleroderma	0.000179	0.00172	CcSEcCtD
Codeine—Mood swings—Methotrexate—systemic scleroderma	0.000179	0.00172	CcSEcCtD
Codeine—Nausea—Mometasone—systemic scleroderma	0.000179	0.00172	CcSEcCtD
Codeine—Anorexia—Lisinopril—systemic scleroderma	0.000179	0.00172	CcSEcCtD
Codeine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000178	0.00171	CcSEcCtD
Codeine—Constipation—Mycophenolic acid—systemic scleroderma	0.000178	0.00171	CcSEcCtD
Codeine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000178	0.00171	CcSEcCtD
Codeine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000177	0.0017	CcSEcCtD
Codeine—Hypotension—Lisinopril—systemic scleroderma	0.000175	0.00168	CcSEcCtD
Codeine—Dizziness—Captopril—systemic scleroderma	0.000175	0.00168	CcSEcCtD
Codeine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000174	0.00167	CcSEcCtD
Codeine—Depression—Prednisone—systemic scleroderma	0.000174	0.00167	CcSEcCtD
Codeine—Urticaria—Leflunomide—systemic scleroderma	0.000173	0.00166	CcSEcCtD
Codeine—Abdominal pain—Leflunomide—systemic scleroderma	0.000172	0.00166	CcSEcCtD
Codeine—Body temperature increased—Leflunomide—systemic scleroderma	0.000172	0.00166	CcSEcCtD
Codeine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000172	0.00165	CcSEcCtD
Codeine—Breast disorder—Methotrexate—systemic scleroderma	0.000171	0.00164	CcSEcCtD
Codeine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000171	0.00164	CcSEcCtD
Codeine—Hypersensitivity—Azathioprine—systemic scleroderma	0.00017	0.00163	CcSEcCtD
Codeine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00017	0.00163	CcSEcCtD
Codeine—Insomnia—Lisinopril—systemic scleroderma	0.00017	0.00163	CcSEcCtD
Codeine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000169	0.00163	CcSEcCtD
Codeine—Vomiting—Captopril—systemic scleroderma	0.000168	0.00162	CcSEcCtD
Codeine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000168	0.00161	CcSEcCtD
Codeine—Dyspnoea—Lisinopril—systemic scleroderma	0.000167	0.00161	CcSEcCtD
Codeine—Rash—Captopril—systemic scleroderma	0.000167	0.0016	CcSEcCtD
Codeine—Dermatitis—Captopril—systemic scleroderma	0.000167	0.0016	CcSEcCtD
Codeine—Somnolence—Lisinopril—systemic scleroderma	0.000167	0.0016	CcSEcCtD
Codeine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000166	0.00159	CcSEcCtD
Codeine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000165	0.00158	CcSEcCtD
Codeine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000165	0.00158	CcSEcCtD
Codeine—Decreased appetite—Lisinopril—systemic scleroderma	0.000163	0.00157	CcSEcCtD
Codeine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000162	0.00155	CcSEcCtD
Codeine—Fatigue—Lisinopril—systemic scleroderma	0.000162	0.00155	CcSEcCtD
Codeine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000162	0.00155	CcSEcCtD
Codeine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000161	0.00155	CcSEcCtD
Codeine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000161	0.00154	CcSEcCtD
Codeine—Pancreatitis—Methotrexate—systemic scleroderma	0.00016	0.00154	CcSEcCtD
Codeine—Constipation—Lisinopril—systemic scleroderma	0.00016	0.00154	CcSEcCtD
Codeine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00016	0.00154	CcSEcCtD
Codeine—Bradycardia—Prednisone—systemic scleroderma	0.00016	0.00153	CcSEcCtD
Codeine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000159	0.00152	CcSEcCtD
Codeine—Nausea—Captopril—systemic scleroderma	0.000157	0.00151	CcSEcCtD
Codeine—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000157	0.00151	CcSEcCtD
Codeine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000157	0.0015	CcSEcCtD
Codeine—Asthenia—Leflunomide—systemic scleroderma	0.000157	0.0015	CcSEcCtD
Codeine—Hallucination—Prednisone—systemic scleroderma	0.000156	0.0015	CcSEcCtD
Codeine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000155	0.00148	CcSEcCtD
Codeine—Pruritus—Leflunomide—systemic scleroderma	0.000154	0.00148	CcSEcCtD
Codeine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000154	0.00147	CcSEcCtD
Codeine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000153	0.00147	CcSEcCtD
Codeine—Dizziness—Azathioprine—systemic scleroderma	0.000153	0.00147	CcSEcCtD
Codeine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000149	0.00143	CcSEcCtD
Codeine—Urticaria—Lisinopril—systemic scleroderma	0.000149	0.00143	CcSEcCtD
Codeine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000149	0.00143	CcSEcCtD
Codeine—Abdominal pain—Lisinopril—systemic scleroderma	0.000148	0.00142	CcSEcCtD
Codeine—Body temperature increased—Lisinopril—systemic scleroderma	0.000148	0.00142	CcSEcCtD
Codeine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000147	0.00141	CcSEcCtD
Codeine—Vomiting—Azathioprine—systemic scleroderma	0.000147	0.00141	CcSEcCtD
Codeine—Eye disorder—Prednisone—systemic scleroderma	0.000146	0.00141	CcSEcCtD
Codeine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000146	0.00141	CcSEcCtD
Codeine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000146	0.0014	CcSEcCtD
Codeine—Drowsiness—Methotrexate—systemic scleroderma	0.000146	0.0014	CcSEcCtD
Codeine—Rash—Azathioprine—systemic scleroderma	0.000146	0.0014	CcSEcCtD
Codeine—Dermatitis—Azathioprine—systemic scleroderma	0.000146	0.0014	CcSEcCtD
Codeine—Depression—Methotrexate—systemic scleroderma	0.000145	0.0014	CcSEcCtD
Codeine—Flushing—Prednisone—systemic scleroderma	0.000145	0.0014	CcSEcCtD
Codeine—Dizziness—Leflunomide—systemic scleroderma	0.000144	0.00139	CcSEcCtD
Codeine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000143	0.00137	CcSEcCtD
Codeine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000142	0.00136	CcSEcCtD
Codeine—Immune system disorder—Prednisone—systemic scleroderma	0.000142	0.00136	CcSEcCtD
Codeine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00014	0.00135	CcSEcCtD
Codeine—Sweating—Methotrexate—systemic scleroderma	0.00014	0.00134	CcSEcCtD
Codeine—Vomiting—Leflunomide—systemic scleroderma	0.000139	0.00133	CcSEcCtD
Codeine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000138	0.00133	CcSEcCtD
Codeine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000138	0.00132	CcSEcCtD
Codeine—Rash—Leflunomide—systemic scleroderma	0.000138	0.00132	CcSEcCtD
Codeine—Dermatitis—Leflunomide—systemic scleroderma	0.000137	0.00132	CcSEcCtD
Codeine—Nausea—Azathioprine—systemic scleroderma	0.000137	0.00132	CcSEcCtD
Codeine—Erythema—Prednisone—systemic scleroderma	0.000136	0.00131	CcSEcCtD
Codeine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000135	0.0013	CcSEcCtD
Codeine—Asthenia—Lisinopril—systemic scleroderma	0.000135	0.00129	CcSEcCtD
Codeine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000134	0.00129	CcSEcCtD
Codeine—Pruritus—Lisinopril—systemic scleroderma	0.000133	0.00127	CcSEcCtD
Codeine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000132	0.00127	CcSEcCtD
Codeine—Rash—Mycophenolic acid—systemic scleroderma	0.000131	0.00126	CcSEcCtD
Codeine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000131	0.00126	CcSEcCtD
Codeine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000131	0.00125	CcSEcCtD
Codeine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00013	0.00125	CcSEcCtD
Codeine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00013	0.00125	CcSEcCtD
Codeine—Nausea—Leflunomide—systemic scleroderma	0.00013	0.00124	CcSEcCtD
Codeine—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000129	0.00124	CcSEcCtD
Codeine—Urethral disorder—Methotrexate—systemic scleroderma	0.000128	0.00123	CcSEcCtD
Codeine—Ill-defined disorder—Prednisone—systemic scleroderma	0.000127	0.00122	CcSEcCtD
Codeine—Visual impairment—Methotrexate—systemic scleroderma	0.000126	0.00121	CcSEcCtD
Codeine—Agitation—Prednisone—systemic scleroderma	0.000125	0.0012	CcSEcCtD
Codeine—Angioedema—Prednisone—systemic scleroderma	0.000125	0.0012	CcSEcCtD
Codeine—Dizziness—Lisinopril—systemic scleroderma	0.000124	0.00119	CcSEcCtD
Codeine—Nausea—Mycophenolic acid—systemic scleroderma	0.000124	0.00119	CcSEcCtD
Codeine—Malaise—Prednisone—systemic scleroderma	0.000123	0.00118	CcSEcCtD
Codeine—Vertigo—Prednisone—systemic scleroderma	0.000123	0.00118	CcSEcCtD
Codeine—Eye disorder—Methotrexate—systemic scleroderma	0.000122	0.00118	CcSEcCtD
Codeine—Syncope—Prednisone—systemic scleroderma	0.000122	0.00117	CcSEcCtD
Codeine—Cardiac disorder—Methotrexate—systemic scleroderma	0.000122	0.00117	CcSEcCtD
Codeine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000121	0.00116	CcSEcCtD
Codeine—Loss of consciousness—Prednisone—systemic scleroderma	0.00012	0.00115	CcSEcCtD
Codeine—Vomiting—Lisinopril—systemic scleroderma	0.000119	0.00114	CcSEcCtD
Codeine—Immune system disorder—Methotrexate—systemic scleroderma	0.000118	0.00114	CcSEcCtD
Codeine—Rash—Lisinopril—systemic scleroderma	0.000118	0.00114	CcSEcCtD
Codeine—Convulsion—Prednisone—systemic scleroderma	0.000118	0.00114	CcSEcCtD
Codeine—Dermatitis—Lisinopril—systemic scleroderma	0.000118	0.00113	CcSEcCtD
Codeine—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000118	0.00113	CcSEcCtD
Codeine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000118	0.00113	CcSEcCtD
Codeine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000116	0.00112	CcSEcCtD
Codeine—Anxiety—Prednisone—systemic scleroderma	0.000116	0.00111	CcSEcCtD
Codeine—Discomfort—Prednisone—systemic scleroderma	0.000115	0.0011	CcSEcCtD
Codeine—Erythema—Methotrexate—systemic scleroderma	0.000114	0.00109	CcSEcCtD
Codeine—Nausea—Lisinopril—systemic scleroderma	0.000111	0.00107	CcSEcCtD
Codeine—Shock—Prednisone—systemic scleroderma	0.00011	0.00105	CcSEcCtD
Codeine—Nervous system disorder—Prednisone—systemic scleroderma	0.000109	0.00105	CcSEcCtD
Codeine—Tachycardia—Prednisone—systemic scleroderma	0.000109	0.00104	CcSEcCtD
Codeine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000109	0.00104	CcSEcCtD
Codeine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000108	0.00103	CcSEcCtD
Codeine—Anorexia—Prednisone—systemic scleroderma	0.000106	0.00102	CcSEcCtD
Codeine—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000106	0.00102	CcSEcCtD
Codeine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000104	0.001	CcSEcCtD
Codeine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000104	0.000995	CcSEcCtD
Codeine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000103	0.000994	CcSEcCtD
Codeine—Malaise—Methotrexate—systemic scleroderma	0.000103	0.000987	CcSEcCtD
Codeine—Vertigo—Methotrexate—systemic scleroderma	0.000102	0.000984	CcSEcCtD
Codeine—Insomnia—Prednisone—systemic scleroderma	0.000101	0.000967	CcSEcCtD
Codeine—Convulsion—Methotrexate—systemic scleroderma	9.88e-05	0.000949	CcSEcCtD
Codeine—Nausea—Mycophenolate mofetil—systemic scleroderma	9.76e-05	0.000937	CcSEcCtD
Codeine—Decreased appetite—Prednisone—systemic scleroderma	9.68e-05	0.000929	CcSEcCtD
Codeine—Fatigue—Prednisone—systemic scleroderma	9.6e-05	0.000922	CcSEcCtD
Codeine—Discomfort—Methotrexate—systemic scleroderma	9.59e-05	0.000921	CcSEcCtD
Codeine—Constipation—Prednisone—systemic scleroderma	9.52e-05	0.000914	CcSEcCtD
Codeine—Confusional state—Methotrexate—systemic scleroderma	9.38e-05	0.000901	CcSEcCtD
Codeine—Feeling abnormal—Prednisone—systemic scleroderma	9.18e-05	0.000881	CcSEcCtD
Codeine—Nervous system disorder—Methotrexate—systemic scleroderma	9.13e-05	0.000876	CcSEcCtD
Codeine—Gastrointestinal pain—Prednisone—systemic scleroderma	9.11e-05	0.000874	CcSEcCtD
Codeine—Hyperhidrosis—Methotrexate—systemic scleroderma	9e-05	0.000864	CcSEcCtD
Codeine—Anorexia—Methotrexate—systemic scleroderma	8.87e-05	0.000852	CcSEcCtD
Codeine—Urticaria—Prednisone—systemic scleroderma	8.85e-05	0.000849	CcSEcCtD
Codeine—Abdominal pain—Prednisone—systemic scleroderma	8.8e-05	0.000845	CcSEcCtD
Codeine—Body temperature increased—Prednisone—systemic scleroderma	8.8e-05	0.000845	CcSEcCtD
Codeine—Hypotension—Methotrexate—systemic scleroderma	8.7e-05	0.000835	CcSEcCtD
Codeine—Insomnia—Methotrexate—systemic scleroderma	8.42e-05	0.000808	CcSEcCtD
Codeine—Dyspnoea—Methotrexate—systemic scleroderma	8.3e-05	0.000797	CcSEcCtD
Codeine—Somnolence—Methotrexate—systemic scleroderma	8.27e-05	0.000794	CcSEcCtD
Codeine—Hypersensitivity—Prednisone—systemic scleroderma	8.2e-05	0.000788	CcSEcCtD
Codeine—Decreased appetite—Methotrexate—systemic scleroderma	8.09e-05	0.000777	CcSEcCtD
Codeine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	8.03e-05	0.000771	CcSEcCtD
Codeine—Fatigue—Methotrexate—systemic scleroderma	8.02e-05	0.00077	CcSEcCtD
Codeine—Asthenia—Prednisone—systemic scleroderma	7.99e-05	0.000767	CcSEcCtD
Codeine—Pruritus—Prednisone—systemic scleroderma	7.88e-05	0.000756	CcSEcCtD
Codeine—Feeling abnormal—Methotrexate—systemic scleroderma	7.67e-05	0.000736	CcSEcCtD
Codeine—Gastrointestinal pain—Methotrexate—systemic scleroderma	7.61e-05	0.000731	CcSEcCtD
Codeine—Urticaria—Methotrexate—systemic scleroderma	7.39e-05	0.00071	CcSEcCtD
Codeine—Dizziness—Prednisone—systemic scleroderma	7.36e-05	0.000707	CcSEcCtD
Codeine—Abdominal pain—Methotrexate—systemic scleroderma	7.36e-05	0.000706	CcSEcCtD
Codeine—Body temperature increased—Methotrexate—systemic scleroderma	7.36e-05	0.000706	CcSEcCtD
Codeine—Vomiting—Prednisone—systemic scleroderma	7.08e-05	0.00068	CcSEcCtD
Codeine—Rash—Prednisone—systemic scleroderma	7.02e-05	0.000674	CcSEcCtD
Codeine—Dermatitis—Prednisone—systemic scleroderma	7.01e-05	0.000674	CcSEcCtD
Codeine—Hypersensitivity—Methotrexate—systemic scleroderma	6.86e-05	0.000658	CcSEcCtD
Codeine—Asthenia—Methotrexate—systemic scleroderma	6.68e-05	0.000641	CcSEcCtD
Codeine—Nausea—Prednisone—systemic scleroderma	6.61e-05	0.000635	CcSEcCtD
Codeine—Pruritus—Methotrexate—systemic scleroderma	6.58e-05	0.000632	CcSEcCtD
Codeine—Dizziness—Methotrexate—systemic scleroderma	6.15e-05	0.000591	CcSEcCtD
Codeine—Vomiting—Methotrexate—systemic scleroderma	5.92e-05	0.000568	CcSEcCtD
Codeine—Rash—Methotrexate—systemic scleroderma	5.87e-05	0.000563	CcSEcCtD
Codeine—Dermatitis—Methotrexate—systemic scleroderma	5.86e-05	0.000563	CcSEcCtD
Codeine—Nausea—Methotrexate—systemic scleroderma	5.53e-05	0.000531	CcSEcCtD
